{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-042129","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.124230+00:00","generated_at":"2026-05-24T12:05:11.057578+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"HCW Biologics amends license deal with WY Biotech; delays $4M upfront payment, adds June 2025 termination option","bullets":["Amended License, Research and Co-Development Agreement dated November 17, 2024, due to CDMO delay.","Restructured $7.0M upfront license fee; initial $4.0M portion originally due March 17, 2025, delayed.","Performance milestones for earning full $7.0M nonrefundable upfront payment reduced; deadline June 2025.","Either party may terminate if WY Biotech cannot definitively engage its CDMO by June 2025.","No other material changes; HCW retains Opt-In Right for Americas."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-042129","json":"https://secwatch.observer/filing/0000950170-25-042129.json","markdown":"https://secwatch.observer/filing/0000950170-25-042129.md","text":"https://secwatch.observer/filing/0000950170-25-042129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025042129/0000950170-25-042129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025042129/hcwb-20250317.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T12:05:11.057578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}